Role of Cerebrospinal Fluid Markers for Predicting Shunt-Dependent Hydrocephalus in Patients with Subarachnoid Hemorrhage and External Ventricular Drain Placement.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 19 07 2018
revised: 19 09 2018
accepted: 20 09 2018
pubmed: 1 10 2018
medline: 3 1 2019
entrez: 1 10 2018
Statut: ppublish

Résumé

We sought to identify potential risk factors for the development of shunt-dependent chronic hydrocephalus after aneurysmal subarachnoid hemorrhage (SAH) and external ventricular drain (EVD) insertion. In particular, the role of inflammatory markers within the cerebrospinal fluid (CSF) was assessed. For this single-center analysis, data were generated from consecutive patients with SAH and the need for EVD implantation treated on our neurosurgical intensive care unit between 2013 and 2015. Parameters were patient characteristics (age, sex, comorbidity), severity of SAH (according to the World Federation of Neurological Society score), imaging findings (intraventricular hemorrhage, diameter of the third ventricle, location of the ruptured aneurysm), and acute course of disease (cerebral infarction, vasospasm). Moreover, the impact of EVD drainage volume and CSF markers (total protein [ Overall, 63 patients (21 males, mean age 55.2 years) were included. Twenty-one patients (30%) developed a shunt-dependent hydrocephalus. Significant risk factors for shunt dependency were the World Federation of Neurological Society score, cerebral infarction, and diameter of the third ventricle (P < 0.05). Moreover, CSF markers associated with shunt-dependent hydrocephalus included increased levels of The time course of selected inflammatory markers in CSF may support management considerations in the early phase after SAH and critical impairment of CSF circulation.

Identifiants

pubmed: 30268545
pii: S1878-8750(18)32205-8
doi: 10.1016/j.wneu.2018.09.159
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e535-e542

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Markus Lenski (M)

Neurochirurgische Klinik und Poliklinik, Klinikum Großhadern, Ludwig Maximilian Universität, Munich, Germany. Electronic address: markus.lenski@med.uni-muenchen.de.

Annamaria Biczok (A)

Neurochirurgische Klinik und Poliklinik, Klinikum Großhadern, Ludwig Maximilian Universität, Munich, Germany.

Volker Huge (V)

Klinik für Anästhesiologie, Klinikum Großhadern, Ludwig Maximilian Universität, Munich, Germany.

Robert Forbrig (R)

Klinik für Neuroradiologie, Klinikum Großhadern, Ludwig Maximilian Universität, Munich, Germany.

Josef Briegel (J)

Klinik für Anästhesiologie, Klinikum Großhadern, Ludwig Maximilian Universität, Munich, Germany.

Jörg-Christian Tonn (JC)

Neurochirurgische Klinik und Poliklinik, Klinikum Großhadern, Ludwig Maximilian Universität, Munich, Germany.

Niklas Thon (N)

Neurochirurgische Klinik und Poliklinik, Klinikum Großhadern, Ludwig Maximilian Universität, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH